Form 4 • Statement of Changes in Beneficial Ownership
Type
Sell
Net shares
-9,533
% of shares
-4.10%
Amount (USD)
$84,271
Insider confidence score
42.5 out of 100
Positive
Negative
Security
Common Stock
Action
Exercise
Date
2026-03-03
Code
M
Net shares
+26,568.0
Acquired/Disposed
Acquired
Shares Owned Before
12,499.0
Shares Owned After
39,067.0
Security
Common Stock
Action
Tax_withhold
Date
2026-03-03
Code
F
Net shares
-9,533.0
Price per Share
$8.84
Amount (USD)
$84,271.72
Acquired/Disposed
Disposed
Shares Owned Before
39,067.0
Shares Owned After
29,534.0
Security
Restricted Stock Units
Action
Exercise
Date
2026-03-03
Code
M
Net shares
-26,568.0
Acquired/Disposed
Disposed
Shares Owned Before
132,841.0
Shares Owned After
106,273.0
1. Each restricted stock unit represents a contingent right to receive one share of ClearPoint Neuro, Inc. ("CLPT") common stock. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date.
2. Represents the amount of shares delivered to CLPT to satisfy applicable tax withholding obligations in connection with the vesting of shares of restricted stock.
3. These shares are owned directly by the Joseph M. Burnett Trust dated 10/20/2022 and indirectly by Joseph M. Burnett as trustee of the trust.
This page is for informational purposes only. While we strive for accuracy, the summary may contain inaccuracies or omissions. Please refer to the official SEC filing for authoritative information. Open the SEC filing.